囊性纤维化患者的营养干预与随诊论文
- 格式:pdf
- 大小:474.53 KB
- 文档页数:7
Intensive nutrition manage—
ment,standardized nutritional intervention and monitoring,dietary guidance
constitute
Hale Waihona Puke enteral nutrition adjustment may
critical measures for improving nutritional
目前存在CF患者28 103例,这一数据在全球可 上升至70 000例旧j。其疾病表现由编码囊性纤维
化跨膜传导调节蛋白(cystic
conductance
fibrosis transmembrane
regulator,CFTR)的基因突变引起编
码蛋白功能缺陷而导致。由于氯离子转运障碍、水 分泌减少、碳酸氢盐等离子跨膜转运受到影响,引
on
their nutritional status
were
evaluated.Results
onset
The mean age of diagnosis of the patients was(19±6)years.All the patients had
recurrent
of pulmonary infection and hypoxemia with varying degrees.The nutritional status was impaired
nutritional status of patients with cystic
fibrosis(CF).Methods
We recruited 6 consecutive
pa-
nn—
tients with CF diagnosed from June 2005 to June 2015 in Peking Union Medical College Hospital,all given
tritional assessment and intervention.The clinical data and nutritional status of the patients were analyzed.Four
cases
were
followed up,and their compliance and effect of nutritional intervention
or
renal
dysfunction),and
decreased prealbumin level in 4 patients.The serum concentrations of Na,C1,
re-
K,and Ca were approximately normal in all the 6 cases.Vitamin D level Was detected in only 2 cases,all vealing vitamin D deficiency.High energy and high protein diet Was suggested
to
increase
body weight.Dietary review of the 3 pa—
tients
with available follow—up data revealed that actual energy intake and protein intake were only 46.1%一
and Peking
Union Medical College,Beijing
To
Corresponding author:Yu
Kang,E-mail:yukl997@sina.com
investigate
【Abstract】Objective
monitoring
on
effect of standardized nutritional assessment.intervention,and
tion was
performed in 3 patients who were suspected with exocrine pancreatic
insufficiency(PI),together
to
with fat—
soluble vitamins supplementation including vitamin D3.Four CF patients were followed up for 1 1 of whom 1 was lost loss
服营养补充剂的支持,可疑胰腺外分泌功能不全的
脏、鼻窦、胰腺、肝脏、胆道、肠道及生殖系统的 外分泌腺,而以呼吸系统损害最为突出。主要临床 表现为鼻窦炎、支气管扩张以及反复的呼吸道感染,
胰腺外分泌功能不全可导致反复腹泻和脂肪泻,此 外男性患者还可以出现先天性输精管缺失旧J。由于
疾病多种因素导致的营养不良以及恶液质是CF常 见的并发症并显著影响疾病的预后与患者的生存时
65.9%and 44.1%-63.2%of recommendation levels.respectively.By enhancing dietary education and gnid—
ance
in follow—up。nutritional
status
of the patients was improved.Conclusion
者均经发汗试验证实汗液氯离子浓度>59
mmol/L;
具有典型临床表现(咳嗽、脓痰,痰病原学检查
起外分泌腺功能障碍,黏稠浓缩的分泌物堆积,堵
塞腺管,引起相应表现。CF多累及包括汗腺、肺
证实为CF常见致病菌铜绿假单胞菌等,影像学证 实弥散性支气管扩张,胰腺外分泌功能不全导致慢 性腹泻等);2例患者行基因检查证实CFTR基因 突变。所有病例临床资料完整。 1.2营养评定、干预与监测 结合临床表现、消化系统症状体征、膳食史、 体质量改变以及实验室检查等对患者进行营养评 定。在控制肺部感染、促进气道排痰的治疗同时, 按照充足能量、蛋白质以及适宜微量营养素摄入的 要求进行个体化营养干预,普通膳食不足者进行口
to
all the patients,plus prescrip-
DOI:10.3760/cma.j.issn.1674—635X.2015.06.002 作者单位:100730中国医学科学院北京协和医学院北京协和医院营养科 通信作者:于康,E—mail:yukl997@sina.com
万方数据
330
500…。
化营养评定、干预、监测的实践,建立循证的临床 营养管理路径,对于改善患者结局、提高生活质 量、节约医疗成本起到至关重要的作用。
1对象与方法 1.1病例纳入 回顾性纳入2005年6月至2015年6月10年间 北京协和医院临床诊断CF的连续病例6例。所有患
2013年美国囊性纤维化注册基金会年鉴报道美国
to
in all the
cases
different extent,with body mass
index(BMI)of 3
patients under 20 years of age being lower
than the third percentile of the standard growth curve for adolescents of the same age and sex.Mild microcytic hypochromic anemia existed in 2 eases,hypoalbuminemia in 2 cases(serum albumin<35 g/L in absence of liver
管理,进行规范化营养干预与监测,指导膳食或肠内营养调整,是改善囊性纤维化患者营养状况的重 要措施。
【关键词】囊性纤维化;营养不足;微量营养素;营养管理 【中图分类号】R459.3 【文献标志码】A 【文章编号】1674—635X(2015)06.0329—07 L/Rongrong,Yu‰昭,Li Chun・
营养状况。 1.3统计学处理 应用SPSS 16.0软件进行统计处理。正态分布
能并不少,如建立更适合中国人的筛查平台,提高 筛检率,有可能发现更大的中国人患病群体…。
华裔CF患者的CFI'R基因突变类型与高加索人种
计量资料采用i±s进行描述。
2
常见突变类型存在一定差异,临床表现不特异,发
汗试验以及基因检查等试验技术尚未在国内大多数
ofMedical
Sci—
Nutritional intervention and follow・up for patients with cystic fibrosis wei.Department
ences
of
Clinical Nutrition,Peking Union Medical College Hospital,Chinese Academy 100730,China
间,营养评价以及干预是欧美CF系统治疗的重要 组成部分。
既往认为CF在亚洲发病较为罕见,目前为止
以单个病例形式报道的中国患病例数不足40例¨J。 但近期遗传学研究发现,CF在中国人中的发病可
情况下给予胰酶替代治疗(pancreatic
placement
enzyme
re—
therapy,PERT)。规律随诊管理,监测
生堡监瘗萱差苤盍!Q!i生!!旦筮垫鲞筮!塑£!i!!堕』!!里尘!!垡!丛趔丛!!巫!i!!:旦!!!坐!竺!!!!:!!!:垫:堕!:!
of oral nutritional supplements for 5 patients.Diagnostic pancreatic enzyme replacement therapy(PERT)